Anti-Human CD326 Recombinant Antibody(Oportuzumab Monatox)

Name: Anti-Human CD326 Recombinant Antibody(Oportuzumab Monatox)
Brand: KMD Bioscience
SKU: YR1637

YR1637

科研级 Oportuzumab Monatox ( 莫妥组单抗 ), Anti-CD326 Recombinant Antibody, Research Grade Oportuzumab Monatox

DATASHEET MSDS

Product Description

Alias	科研级 Oportuzumab Monatox ( 莫妥组单抗 ), Anti-CD326 Recombinant Antibody, Research Grade Oportuzumab Monatox
Catalog Number	YR1637
Molecular Name	Oportuzumab Monatox
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	scFv Kappa-heavy
Formulation	PBS, pH7.5
Background	Oportuzumab monatox (proposed INN, trade name Vicineum) is an antineoplastic. Chemically, oportuzumab is a single chain variable fragment of a monoclonal antibody which binds to epithelial cell adhesion molecule (EpCAM, the tumor-associated calcium signal transducer 1).
CAS Number	945228-48-8
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	CD326[Homo sapiens]

Login